Phase II Clinical Development of New Drugs
| dc.contributor.author | Ting, Naitee | |
| dc.date.accessioned | 2019-02-01T07:43:44Z | |
| dc.date.accessioned | 2024-06-29T09:47:19Z | |
| dc.date.available | 2019-02-01T07:43:44Z | |
| dc.date.available | 2024-06-29T09:47:19Z | |
| dc.date.issued | 2017 | |
| dc.identifier.isbn | 978-981-10-4194-5 | |
| dc.identifier.uri | https://drs.ess.gov.et/handle/123456789/39466 | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer | en_US |
| dc.subject | Statisticsn ; Management ; Pharmaceutical technology. | en_US |
| dc.title | Phase II Clinical Development of New Drugs | en_US |
| dc.type | Book | en_US |